منابع مشابه
Severe pretibial myxedema.
Although pretibial myxedema (PTM) occurs in 4.3% of patients with Graves's disease, the most severe variant, elephantiasis nostras verrucosa, is found in less than 1% of cases. The most frequent location of infiltration is the lower extremities, especially the pretibial areas and on the dorsum of the foot. The authors report one of the most severe cases of elephantiasis nostras verrucosa, follo...
متن کاملEuthyroid pretibial myxedema and EMO syndrome.
EMO syndrome is a rare extrathyroid syndrome, seen in only 1% of patients affected by extrathyroid complications of Graves' disease. A 73-year-old woman presented with a 1-year history of asymptomatic local swellings on her legs and feet. Physical examination revealed moderate proptosis and multiple, firm subcutaneous nodules of 1 to 5 cm in diameter located on the anterior and medial aspects o...
متن کاملElephantiasic Pretibial Myxedema with Involvement of the Buttocks and Face
To the Editor: Pretibial myxedema (PTM), a localized thyroid-associated dermopathy, is characterized by local thickening and remodeling of the skin − it is often associated with a group of autoimmune thyroid diseases (ATDs).[1] PTM is most frequently located across the lower legs, especially the pretibial areas or the dorsum of the foot. Rarely, the fingers and hands, elbows, arms, or face are ...
متن کاملIntralesional Hyaluronidase with Triamcinolone for Recalcitrant Pretibial Myxedema
INTRALESIONAL HYALURONIDASE WITH TRIAMCINOLONE FOR RECALCITRANT PRETIBIAL MYXEDEMA Abstract Pretibial myxedema resulting in progressively worsening cutaneous induration and expanding nodules can lead to pain, discomfort and functional impairment. Treatment of resistant lesions presents a special challenge whereby topical therapies are insufficient, and systemic therapies are met with poor toler...
متن کاملTreatment of pretibial myxedema with intralesional immunomodulating therapy
OBJECTIVE Local immune regulation therapy has been one of the therapeutic methods used for the treatment of autoimmune thyroid disease in patients with pretibial myxedema (PTM). However, the poor response rate and high recurrence rate are still major problems. Whether a premixed corticosteroid, compound betamethasone, could enhance remission rate and decrease recurrence rate in patients with PT...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Case Reports and Images
سال: 2013
ISSN: 0976-3198
DOI: 10.5348/ijcri-2013-12-413-cr-7